Full-Time

Senior Computational Biology

Real World Data Science

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Senior

Chicago, IL, USA

Category
Bioinformatics
Computational Biology
Biology & Biotech
Data & Analytics
Required Skills
Python
R
Data Structures & Algorithms
SQL
Requirements
  • PhD degree in a quantitative discipline (e.g. Biostatistics/Statistical Genetics, Cancer Genetics, Bioinformatics, Computational Biology, Computational Immunology, or similar) plus 2 years of experience or postdoctoral studies.
  • Alternatively, a PhD in Molecular Biology or Immunology combined with a very strong record of computational biology.
  • Minimum 2+ years in drug development leveraging genomic and multimodal data for drug discovery and development.
  • Proficient in R, Python, and SQL.
  • Strong understanding of cancer biology.
  • Excellent written and verbal communication skills, with the ability to present complex information clearly and persuasively to diverse audiences.
Responsibilities
  • Perform bioinformatics analyses for large-scale research projects, such as detailed target characterization, biomarker discovery, or identifying the ideal patient population for a specified therapeutic.
  • Project management, including creating research plans, executing research aims, supervising other bioinformaticians, and creating reports and other deliverables.
  • Develop methods for analyzing multi-omics data, building analysis pipelines, algorithms, and validating tools for oncology research.
  • Collaborate with scientists to understand their research questions and propose solutions.
  • Write clean, maintainable, documented code.
  • Independently execute complex research projects integrating molecular and clinical data to derive real-world insights for biopharma partners.
  • Expert in navigating client interactions; Present scientific findings clearly and meaningfully to diverse sets of external stakeholders.
  • Document, summarize, and communicate highly technical results and methods clearly to non-technical audiences.
  • Stay current with industry trends, best practices, and advancements in computational oncology research. Apply this knowledge to enhance research methodologies and improve overall research quality on the team.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

14%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Integration with Flatiron's OncoEMR enhances genomic data accessibility for oncologists.
  • Acquisition of Ambry Genetics expands Tempus's capabilities in medical diagnostics and testing.
  • Collaboration with BioNTech leverages real-world data for enhanced drug development.

What critics are saying

  • Ambry Genetics acquisition may strain financial resources and impact operational efficiency.
  • Collaboration with Flatiron Health may face data privacy and interoperability issues.
  • Immune Profile Score algorithmic test may encounter regulatory scrutiny, delaying adoption.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and evaluating treatments.
  • Tempus's pan-cancer organoid platform enhances personalized therapeutic opportunities for cancer patients.

Help us improve and share your feedback! Did you find this helpful?